Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man
- 1 July 1987
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 18 (1) , 51-61
- https://doi.org/10.1016/0167-0115(87)90050-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The distributions of PHI and VIP in porcine gut and their co-localisation to a proportion of intrinsic ganglion cellsPeptides, 1984
- DIARRHOEA IN VIPOMA PATIENTS ASSOCIATED WITH COSECRETION OF A SECOND ACTIVE PEPTIDE (PEPTIDE HISTIDINE ISOLEUCINE) EXPLAINED BY SINGLE CODING GENEThe Lancet, 1983
- Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27Nature, 1983
- Effects of Porcine Intestinal Heptacosapeptide and Vasoactive Intestinal Polypeptide on Insulin and Glucagon Secretion in Rats*Endocrinology, 1983
- Vascular effects of the peptides PYY and PHI: Comparison with APP and VIPEuropean Journal of Pharmacology, 1982
- Porcine peptide having N‐terminal histidine and C‐terminal isoleucine amide (PHI)FEBS Letters, 1980
- Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptidesNature, 1980
- Peptidergic (VIP) nerves in the pancreasHistochemistry and Cell Biology, 1978
- Structure of the Porcine Vasoactive Intestinal OctacosapeptideEuropean Journal of Biochemistry, 1974
- Polypeptide with Broad Biological Activity: Isolation from Small IntestineScience, 1970